
### [NCIT:C4107](http://purl.obolibrary.org/obo/NCIT_C4107)
**Label:** Nasopharyngeal Type Undifferentiated Carcinoma

**Subclasses:** [NCIT:C8229](http://purl.obolibrary.org/obo/NCIT_C8229) (Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8227](http://purl.obolibrary.org/obo/NCIT_C8227) (Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C7998](http://purl.obolibrary.org/obo/NCIT_C7998) (Thymic Lymphoepithelioma-Like Carcinoma), [NCIT:C8225](http://purl.obolibrary.org/obo/NCIT_C8225) (Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C6035](http://purl.obolibrary.org/obo/NCIT_C6035) (Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8), [NCIT:C8223](http://purl.obolibrary.org/obo/NCIT_C8223) (Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115089](http://purl.obolibrary.org/obo/NCIT_C115089) (Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115088](http://purl.obolibrary.org/obo/NCIT_C115088) (Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115087](http://purl.obolibrary.org/obo/NCIT_C115087) (Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C8023](http://purl.obolibrary.org/obo/NCIT_C8023) (Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086) (Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C8231](http://purl.obolibrary.org/obo/NCIT_C8231) (Recurrent Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C115093](http://purl.obolibrary.org/obo/NCIT_C115093) (Recurrent Oropharyngeal Undifferentiated Carcinoma), [NCIT:C45519](http://purl.obolibrary.org/obo/NCIT_C45519) (Lymphoepithelioma-Like Lung Carcinoma), [NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant), [NCIT:C68610](http://purl.obolibrary.org/obo/NCIT_C68610) (Oropharyngeal Undifferentiated Carcinoma), [NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma), [NCIT:C35736](http://purl.obolibrary.org/obo/NCIT_C35736) (Salivary Gland Lymphoepithelial Carcinoma), [NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40137](http://purl.obolibrary.org/obo/NCIT_C40137) (Uterine Ligament Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 38.93%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C40128](http://purl.obolibrary.org/obo/NCIT_C40128) (Fallopian Tube Leiomyosarcoma))) 38.93%


